Abiraterone Acetate bulk supplier for pharma manufacturers

Abiraterone Acetate 250 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 250 mg, 500 mg

Reference Brands: Zytiga®(EU & US)

Abiraterone Acetate Tablets are oral oncology drugs used to treat metastatic prostate cancer. Available in 250 mg and 500 mg strengths, they are approved in both the U.S. and EU, commonly marketed as Zytiga® or in generic form. Used with prednisone, Abiraterone helps block androgen production and slow cancer growth.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Abiraterone Acetate Tablets, available in 250 mg and 500 mg strengths, are a key oral oncology product used in treating metastatic prostate cancer. Approved across the U.S. and EU, Abiraterone inhibits androgen biosynthesis by targeting the CYP17 enzyme, effectively suppressing tumor growth in hormone-sensitive prostate cancers. Marketed under the brand name Zytiga® and widely available as generics, this therapy is often used alongside prednisone. Abiraterone Acetate is a vital product for pharma B2B oncology portfolios, offering significant therapeutic benefit and global demand in both hospital and retail oncology markets.

Abiraterone Acetate — third party manufacturing & bulk supply

Abiraterone Acetate 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Abiraterone Acetate is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Abiraterone Acetate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Abiraterone Acetate →

Back to Listing

Frequently Asked Questions

Abiraterone Acetate is listed as Tablet in 250 mg, 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Abiraterone Acetate is referenced against Zytiga®(EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.